Authors:
Maisano, R
Spadaro, P
Toscano, G
Caristi, N
Pergolizzi, S
Salimbeni, V
Citation: R. Maisano et al., Cisapride and dexamethasone in the prevention of delayed emesis after cisplatin administration, SUPP CARE C, 9(1), 2001, pp. 61-64
Authors:
Ferri, R
Elia, M
Musumeci, SA
Cosentino, FII
Roccasalva, G
Spada, RS
Toscano, G
Citation: R. Ferri et al., Somatosensory evoked potentials in patients affected by unilateral cerebrovascular lesions with onset during the perinatal period or adulthood, J CHILD NEU, 16(8), 2001, pp. 541-547
Authors:
Spada, RS
Cento, RM
Proto, C
Ferri, R
Roccasalva, G
Toscano, G
Cosentino, FII
Lanzone, A
Citation: Rs. Spada et al., Twenty-four-hour urinary free cortisol levels in vascular dementia and in Alzheimer's disease, ARCH GER G, 2001, pp. 363-367
Authors:
Rizzoli, G
Guglielmi, C
Toscano, G
Pistorio, V
Vendramin, I
Bottio, T
Thiene, G
Casarotto, D
Citation: G. Rizzoli et al., Reoperations for acute prosthetic thrombosis and pannus: an assessment of rates, relationship and risk, EUR J CAR-T, 16(1), 1999, pp. 74-80
Authors:
Rella, R
Siciliano, P
Toscano, G
Valli, L
Schenetti, L
Mucci, A
Iarossi, D
Citation: R. Rella et al., Langmuir-Blodgett films of poly[3-(butylthio)thiophene]: optical properties and electrical measurements in controlled atmosphere, SENS ACTU-B, 57(1-3), 1999, pp. 125-129
Authors:
Gianfreda, L
Saccomandi, F
Filazzola, MT
Rao, MA
Greco, G
Toscano, G
Citation: L. Gianfreda et al., Innovative strategies for the recovery of LNAPL contaminated sites by in situ bioremediation, HUMAN AND ENVIRONMENTAL EXPOSURE TO XENOBIOTICS, 1999, pp. 707-713
Authors:
Capodaglio, G
Turetta, C
Toscano, G
Gambaro, A
Scarponi, G
Cescon, P
Citation: G. Capodaglio et al., Cadmium, lead and copper complexation in antarctic coastal seawater. Evolution during the austral summer, INT J ENV A, 71(3-4), 1998, pp. 195-226
Authors:
Bretti, S
Berruti, A
Dogliotti, L
Castagneto, B
Bertulli, R
Spadaro, P
Toscano, G
Astorre, P
Verusio, C
Lionetto, R
Bruzzi, P
Santoro, A
Citation: S. Bretti et al., Combined epirubicin and interleukin-2 regimen in the treatment of malignant mesothelioma: A multicenter phase II study of the Italian Group on Rare Tumors, TUMORI, 84(5), 1998, pp. 558-561